Subscribe To
Astria therapeutics to present new star-0215 data at the 2023 american college of allergy, asthma, and immunology annual scientific meeting
BOSTON--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allerg...
November 3, 2023, 8:10 am
Dbv technologies to present new data at acaai 2023
Montrouge, France, November 2, 2023 DBV Technologies to Present New Data at ACAAI 2023 New data to include late-breaking abstract detailing interim 12...
November 2, 2023, 4:30 pm
Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
November 2, 2023, 6:30 am
Pharvaris to present at the apaaaci 2023 international conference
ZUG, Switzerland, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin B2 receptor a...
October 13, 2023, 6:50 am
Valeo pharma reports record quarterly revenue or strong demand for enerzair and atectura therapies
Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) has reported its seventh consecutive rise in revenues to a quarterly record due to strong growth in its Enerz...
September 14, 2023, 8:16 am
: medicare patients paid 4 times as much as their drug plans for certain medicines, study finds
People with diabetes, asthma, and other conditions often pay higher prescription costs that effectively...
September 7, 2023, 3:56 pm
Honeywell (hon), recipharm unite to develop near-zero gwp pmdis
The deal between Honeywell (HON) and Recipharm allows them to offer low greenhouse gas pMDIs to patients suffering from COPD and ...
August 18, 2023, 2:04 pm
Ipo update: apogee therapeutics proposes terms for $250 million ipo
Apogee Therapeutics, Inc. has filed proposed terms for a $250 million IPO. The firm is developing drug treatment candidates for atopic dermatitis, COP...
July 10, 2023, 5:33 pm
Merck accused of downplaying early evidence of drug's brain impact
An early magazine advertisement for Merck's breakthrough asthma and allergy medicine, Singulair, featur...
June 26, 2023, 6:07 am
Pieris (pirs) declines as azn halts study of asthma candidate
Pieris' (PIRS) shares nosedive as its partner decides to discontinue a phase IIa study evaluating elarekibep for treating ...
June 23, 2023, 11:54 am
World asthma day 2023: 3 tips to prevent cardiac asthma
Cardiac asthma is a medical condition that is caused by congestive heart failure (CHF), a condition in ...
May 2, 2023, 7:59 am
Arrowhead pharmaceuticals shares rise on positive interim trial results
Arrowhead Pharmaceuticals has released positive interim results from its Phase 1/2 study of its investigational therapeutic ARO-RAGE for inflammatory ...
April 25, 2023, 11:07 am
Rapt therapeutics: potential strong upside ahead
RAPT Therapeutics, Inc. is a clinical-stage biotech developer of specific small molecules that can modulate the critical immune drivers of inflammator...
March 30, 2023, 12:12 am
Sanofi, regeneron shares pop more than 6% after data shows asthma drug dupixent may also treat copd
Sanofi and Regeneron unveiled data on their jointly developed drug for a difficult-to-treat chronic lung disorder that analysts say "exceeded expectat...
March 23, 2023, 2:31 pm
Regeneron, sanofi soar on blow-out results in 'smoker's lung'
Sanofi and Regeneron's asthma drug Dupixent succeeded in a study of patients with "smoker's lung," lead...
March 23, 2023, 9:03 am
Verona pharma: strong stock growth potential from a promising new drug
Verona Pharma's ensifentrine achieved positive results in a Phase 3 study with an indication for COPD. Ensifentrine is also in Phase 2 studies to addr...
March 12, 2023, 4:00 am
A woman dismissed her exhaustion as anxiety, asthma, and menopause. she actually needed a heart transplant and brain surgery.
Ann Ramirez Dudas was 48 when she was diagnosed with congestive heart failure. She would need a new heart, but first, surgeons removed a brain tumor. ...
February 26, 2023, 10:44 pm
Pulmatrix to present data on pur1800 at the annual meeting of the american academy of allergy, asthma and immunology
LEXINGTON, Mass. , Jan. 23, 2023 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inha...
January 23, 2023, 9:05 am
Fda approves astrazeneca's new treatment for people with asthma
AstraZeneca AZN, +0.99% AZN, -0.27% said Wednesday that the Food and Drug Administration approved a new therapy that can be used to treat or prevent b...
January 11, 2023, 8:38 am
Physicians for informed consent (pic) updates its ‘aluminum – vaccine risk statement’: document includes data on association between aluminum in vaccines and childhood asthma
According to PIC, adverse effects of aluminum may not be restricted to neurological conditions* Number of Aluminum-Containing Vaccine Doses Administer...
December 29, 2022, 1:01 am